NASDAQ:TLRY

Tilray Inc. (TLRY)

4.64
+0.10 (2.20%)
as of Aug 3, 2026, 8:00:00 pm Market Open.
91 watching
0
Investor Insights
star iconAug 4, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Tilray Inc. (TLRY-Q) is facing significant challenges in revenue generation, with recent reports indicating a decline in revenue of 6.6% and a striking 32% in two different quarters. The company generated a revenue of $288 million in one instance and $210 million in another, reflecting ongoing struggles in the cannabis market. Additionally, gross profit has also taken a hit, with a 14.9% and 38.1% decrease reported respectively. These figures raise concerns about the demand for Tilray's products and its operational efficiency moving forward. Despite a notable increase in social media mentions, which surged by 28.2% and 24.9%, analysts suggest further investigation into the underlying issues affecting the company's performance. Some experts recommend that investors consider using Tilray as a tax loss, highlighting a cautious outlook on its future prospects.

consensus icon
Consensus
bearish
valuation icon
Valuation
overvalued
review icon
Similar
Cronos,CRON
DON'T BUY
It reports Monday. Pot stocks have been devastating. Since 2018, this has been all downhill. Let's see if the CEO can change direction.
BUY ON WEAKNESS
Bullish on medical marijuana. We will see legalizing banking in the US for the sector. There will be volatility. He sold into strength. Likes it here. Has lots of upside potential.
COMMENT
It will be a big industry that will be huge in the future. There is still 30%-50% upside in the future. The question should be whether you would add new money or not. If you do not want to , it is time to cash out.
DON'T BUY
There's lower highs and lower lows. He would look elsewhere for better potential.
DON'T BUY
He would not buy this. It collapsed from $350. Not the story he invests in. A long term story, hopefully with another couple years of losses yet to come. Too risky for him.
COMMENT
There is some downside pressure on HMMJ-T. At the $14 or $17 range there is resistance. Who knows what the effect would be if the government changes in October. [Caller asked about TLRY] He sees $34 as a target on TLRY-T as there is nothing to hold it higher.
Showing 16 to 22 of 22 entries